Common Rheumatoid Arthritis and Psoriasis Medications Are Associated with Reduced Diabetes Risk
Two disease-modifying antirheumatic drugs, TNF inhibitors and hydroxychloroquine, are associated with a reduced risk for the development of diabetes in psoriasis and rheumatoid arthritis patients.
Source: BWH News - Category: Hospital Management Source Type: news
More News: Arthritis | Diabetes | Endocrinology | Hydroxychloroquine | Psoriasis | Rheumatoid Arthritis | Rheumatology